Yesterday, Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) presented data at the European Lupus Meeting, which indicates 70% of patients achieved complete remission (CR) at 24 …
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is a biopharmaceutical company known for developing drug treatments for chronic liver diseases. The company’s current leading drug is …